Alpha Cognition Inc (TSE:ACOG) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Alpha Cognition Inc. has released promising interim preclinical data for its drug ALPHA-1062, aimed at treating mild traumatic brain injuries caused by repetitive blast trauma, a common military injury. The study, supported by the US Department of Defense, shows that ALPHA-1062 reduces neuroinflammation and neuropathology in the brain. This progress signals a potential breakthrough in treating brain injuries related to military service.
For further insights into TSE:ACOG stock, check out TipRanks’ Stock Analysis page.
